(Q33625135)

28 July 2017

title

Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir (English)

1 reference

28 July 2017

0 references

1 reference

1 reference

1 reference

Kristin H Busse

1

1 reference

28 July 2017

Colleen Hadigan

2

1 reference

28 July 2017

Cheryl Chairez

3

1 reference

28 July 2017

Raul M Alfaro

4

1 reference

28 July 2017

Elizabeth Formentini

5

1 reference

28 July 2017

Joseph A Kovacs

6

1 reference

28 July 2017

Scott R Penzak

7

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Journal of Acquired Immune Deficiency Syndromes

28 July 2017

published in

1 reference

28 July 2017

volume

52

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

235-239

1 reference

Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

HIV therapy, metabolic syndrome, and cardiovascular risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Intestinal drug transporter expression and the impact of grapefruit juice in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Management of protease inhibitor-associated hyperlipidemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Pharmacokinetics of the combination of fluvastatin and gemfibrozil

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Gemfibrozil in a group of diabetics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Ten-year predicted coronary heart disease risk in HIV-infected men and women.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Possible interaction between lopinavir/ritonavir and valproic Acid exacerbates bipolar disorder

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Cardiovascular disease in HIV-positive patients.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815103

Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

30 October 2018

1 reference

12 December 2020

Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

1 reference

12 December 2020

Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients

1 reference

12 December 2020

Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects

1 reference

12 December 2020

Metabolism of Fibric Acid Derivatives

1 reference

12 December 2020

Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients

1 reference

12 December 2020

Gemfibrozil in the treatment of dyslipidaemias in middle-aged male survivors of myocardial infarction

1 reference

12 December 2020

Assay of gemfibrozil in plasma by "high-performance" liquid chromatography

1 reference

12 December 2020

The effect of renal function on the pharmacokinetics of gemfibrozil

1 reference

12 December 2020

Apparent reduced absorption of gemfibrozil when given with colestipol

1 reference

12 December 2020

10.1097/QAI.0B013E3181B0610E

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference